Sharps Technology Completes Private Funding Round on August 25, 2025

According to industry reports, Sharps Technology completed a private funding round on August 25, 2025. The round attracted investment from prominent institutions including Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology is a NASDAQ-listed medical device company (ticker: STSS) specializing in the development and manufacturing of innovative safety syringes. The company is dedicated to reducing disease transmission risks caused by needlestick injuries through its technology, safeguarding healthcare professionals, patients, and the public, while also enhancing the accuracy and efficiency of drug delivery.Recent updates indicate that Sharps Technology has established a SOL treasury and expanded its fundraising target to USD 1 billion by the end of August 2025, simultaneously launching a digital asset reserve strategy. As of September 2, 2025, the company’s SOL holdings exceeded 2 million tokens. Notably, the company has also completed over USD 400 million in PIPE private placement financing to create the SOL treasury, underscoring institutional investors’ strong confidence in the company’s strategic direction.This funding round not only highlights sustained market attention toward innovation in medical technology but also reflects how traditional healthcare enterprises are actively embracing new opportunities in digital assets. Such cross-sector integration is poised to bring fresh momentum and innovative possibilities to the medical industry.